HIMS
HIMS Stock Snaps 3-Day Losing Streak: FDA Adds 8 New Peptide Voters Deemed More Qualified And Less Conflicted
Article Summary
HOLD- Hims & Hers Health Inc. (NYSE: HIMS) rebounded slightly after FDA expanded its peptide advisory panel with eight new voting members ahead of a crucial review of seven unapproved compounds, including BPC-157, KPV, TB-500, MOTS-c, Emideltide, Semax and Epitalon, with former FDA official Peter Lurie calling additions considerably more qualified and less conflicted than earlier nominees.
- Hims & Hers Health's stock rose 0.1% on Tuesday after a three-day losing streak but remains on track for its worst month since February.
- The panel will evaluate seven compounds for possible inclusion on the Section 503A Bulks List, which could give certain licensed pharmacies a clearer legal route to compound the substances for individual patients.
Free users see 3 BUY signals per day. Premium unlocks all of them, plus instant email alerts.
See Plans
Growth Stock Scoring Breakdown
| METRIC | VALUE | WEIGHT | ANALYSIS |
|---|---|---|---|
| Sales Growth TTM ? | 32.8% | 25% | 85.0 ptsExcellent (32.8%) - Strong growth |
| EPS Growth Next 5Y ? | 15.2% | 25% | 50.0 ptsMeets Minimum (15.2%) - Passes screener |
| Target Price Upside ? | 8.3% | 20% | 10.0 ptsNear/At Target (8.3%) - Target: $29.85 vs Current: $32.55 |
| Gross Margin % ? | 57.5% | 15% | 80.0 ptsVery Healthy (57.5%) - High-quality margins |
| Drawdown from 52-Wk High ? | -53.8% | 15% | 100.0 ptsDeep Discount (-53.8%) - Best entry opportunity |
Disclaimer: This rating is for informational purposes only and is not financial advice.
All data sourced from Finviz.
Always conduct your own research and consult with a financial advisor before making investment decisions.
Past performance does not guarantee future results.
About HIMS
- Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
- The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
- It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers.
- Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services.
- Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health.
- The company offers its products through retail partnerships, in stores, and online.
- Hims & Hers Health, Inc. is based in San Francisco, California.